Life360 (NASDAQ:LIF – Get Free Report) had its price objective upped by equities researchers at Canaccord Genuity Group from $54.00 to $58.00 in a research report issued to clients and investors on ...

Hims & Hers Health (NYSE:HIMS – Get Free Report) had its price objective increased by equities research analysts at Canaccord Genuity Group from $28.00 to $38.00 in a report released on ...

Intellia Therapeutics Inc (NTLA) stock saw a modest uptick, ending the day at $15.73 which represents a slight increase of $0.11 or 0.70% from the prior close of $15.62. The stock opened at $15.66 and ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 25.48% ...

The stock market is on track to end 2024 on a high note, with select equities likely to see further upside in the coming year ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

Shares of streaming giant Netflix Inc (NASDAQ: NFLX) have been on a tear this year, making 2024 one for the history books. The stock has surged almost 100% since January and was hitting fresh ...

As a tough year for ASX lithium shares draws to an end, are the commodity's premium producers set to see daylight in 2025?

Coelacanth Energy Inc. (V.CEI) hit a new 52-week high of 94 cents Tuesday. Coelacanth announces that it has completed and tested four additional wells at its Two Rivers East Project including four ...

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, ...

Two equity analysts from top Wall Street firms revised their price targets for Netflix stock upward - but they see little ...

In a report released today, Susan Anderson from Canaccord Genuity reiterated a Buy rating on Ulta Beauty (ULTA – Research Report), with a price ...